| Primary |
| Diabetes Mellitus |
36.9% |
| Drug Use For Unknown Indication |
13.9% |
| Type 2 Diabetes Mellitus |
13.4% |
| Hypertension |
13.2% |
| Angina Pectoris |
2.4% |
| Cardiac Failure |
2.2% |
| Diabetes |
2.0% |
| Diabetes Mellitus Non-insulin-dependent |
1.5% |
| Hyperlipidaemia |
1.5% |
| Osteonecrosis |
1.5% |
| Blood Glucose Abnormal |
1.2% |
| Constipation |
1.2% |
| Depression |
1.2% |
| Hypercholesterolaemia |
1.2% |
| Mitral Valve Replacement |
1.2% |
| Renal Failure Chronic |
1.2% |
| Schizophrenia |
1.2% |
| Arteriosclerosis |
1.0% |
| Myocardial Infarction |
1.0% |
| Nasopharyngitis |
1.0% |
|
| Hypoglycaemia |
14.0% |
| Vomiting |
9.6% |
| Pneumatosis Intestinalis |
8.8% |
| Hypoglycaemic Coma |
7.9% |
| Intestinal Obstruction |
7.9% |
| Diabetes Mellitus Inadequate Control |
5.3% |
| Weight Decreased |
5.3% |
| Blood Glucose Increased |
4.4% |
| Diarrhoea |
4.4% |
| Liver Disorder |
4.4% |
| Malaise |
3.5% |
| Palpitations |
3.5% |
| Abdominal Distension |
2.6% |
| Alpha 1 Foetoprotein Increased |
2.6% |
| Dizziness |
2.6% |
| Gastric Cancer |
2.6% |
| Headache |
2.6% |
| Hepatic Enzyme Increased |
2.6% |
| Ileus |
2.6% |
| Intestinal Haemorrhage |
2.6% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.7% |
| Diabetes Mellitus |
21.7% |
| Type 2 Diabetes Mellitus |
11.9% |
| Schizophrenia |
10.7% |
| Hypertension |
8.6% |
| Constipation |
3.5% |
| Rheumatoid Arthritis |
3.3% |
| Cerebral Infarction |
1.9% |
| Product Used For Unknown Indication |
1.4% |
| Benign Prostatic Hyperplasia |
1.2% |
| Gastric Ulcer |
1.2% |
| Hepatic Neoplasm Malignant |
1.2% |
| Prophylaxis |
1.2% |
| Urethritis |
1.2% |
| Blood Albumin Decreased |
0.9% |
| Diabetes Mellitus Non-insulin-dependent |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Oral Mucosa Erosion |
0.9% |
| Parkinson's Disease |
0.9% |
| Cardiac Failure Chronic |
0.7% |
|
| Urinary Retention |
21.4% |
| Liver Disorder |
9.5% |
| Hypoglycaemia |
8.3% |
| Liver Function Test Abnormal |
8.3% |
| Intestinal Obstruction |
6.0% |
| Myocardial Infarction |
4.8% |
| Aspartate Aminotransferase Increased |
3.6% |
| Diabetes Mellitus Inadequate Control |
3.6% |
| Hypoglycaemic Coma |
3.6% |
| Pyrexia |
3.6% |
| Rhabdomyolysis |
3.6% |
| Urinary Tract Infection |
3.6% |
| Vomiting |
3.6% |
| Breast Cancer |
2.4% |
| Drug Interaction |
2.4% |
| Hyperkalaemia |
2.4% |
| Ileus |
2.4% |
| Lymphocyte Stimulation Test Positive |
2.4% |
| Poriomania |
2.4% |
| Suspected Counterfeit Product |
2.4% |
|
| Concomitant |
| Diabetes Mellitus |
25.8% |
| Hypertension |
19.9% |
| Type 2 Diabetes Mellitus |
10.8% |
| Drug Use For Unknown Indication |
9.4% |
| Product Used For Unknown Indication |
5.7% |
| Prophylaxis |
3.2% |
| Hyperlipidaemia |
2.5% |
| Constipation |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Cardiac Failure Congestive |
2.3% |
| Cardiac Failure Chronic |
2.1% |
| Insomnia |
1.9% |
| Hypercholesterolaemia |
1.8% |
| Chronic Myeloid Leukaemia |
1.7% |
| Osteoporosis |
1.7% |
| Colorectal Cancer |
1.4% |
| Cardiac Failure |
1.3% |
| Hepatic Neoplasm Malignant |
1.3% |
| Gastric Ulcer |
1.3% |
| Cerebral Infarction |
1.2% |
|
| Vomiting |
8.4% |
| Weight Decreased |
7.6% |
| Rash |
6.8% |
| Death |
6.0% |
| Renal Failure Acute |
6.0% |
| Renal Impairment |
6.0% |
| Cerebral Infarction |
5.6% |
| Hypoglycaemia |
5.6% |
| Interstitial Lung Disease |
5.6% |
| Hepatic Function Abnormal |
5.2% |
| Liver Disorder |
4.8% |
| Bladder Cancer |
4.4% |
| Vision Blurred |
4.0% |
| Hyperglycaemia |
3.6% |
| Rhabdomyolysis |
3.6% |
| Thrombocytopenia |
3.6% |
| Cardiac Failure |
3.2% |
| Malaise |
3.2% |
| Pneumonia |
3.2% |
| Renal Failure |
3.2% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
23.4% |
| Angina Pectoris |
17.5% |
| Drug Use For Unknown Indication |
12.4% |
| Hypertension |
10.9% |
| Diabetes Mellitus |
9.5% |
| Upper Respiratory Tract Inflammation |
8.8% |
| Hyperlipidaemia |
4.4% |
| Multiple Myeloma |
4.4% |
| Osteoporosis |
4.4% |
| Upper Respiratory Tract Infection |
4.4% |
|
| Hypoglycaemia |
50.0% |
| Muscular Weakness |
16.7% |
| Upper Respiratory Tract Infection |
16.7% |
| Thrombocytopenia |
11.1% |
| Acute Respiratory Failure |
5.6% |
|
